Ultragenyx Reports Second Quarter 2018 Financial Results and Corporate Update
Go back to Ultragenyx Reports Second Quarter 2018 Financial Results and Corporate Update| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.88 | 52 Week High | $117.12 | |||
| Open | $14.88 | 52 Week Low | $46.52 | |||
| Day High | $14.88 | P/E | N/A | |||
| Day Low | $14.88 | EPS | $-1.97 | |||
| Volume | 3,382 | |||||
